208 related articles for article (PubMed ID: 25447209)
1. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Ting CT; Li WC; Chen CY; Tsai TH
J Chin Med Assoc; 2015 Mar; 78(3):139-44. PubMed ID: 25447209
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
3. A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.
Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L
Integr Cancer Ther; 2018 Sep; 17(3):902-911. PubMed ID: 29775121
[TBL] [Abstract][Full Text] [Related]
4. A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.
Jianxin C; Qingxia X; Junhui W; Qinhong Z
Integr Cancer Ther; 2017 Dec; 16(4):597-604. PubMed ID: 27444311
[TBL] [Abstract][Full Text] [Related]
5. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma.
Hu B; An HM; Wang SS; Chen JJ; Xu L
Molecules; 2016 Jan; 21(2):142. PubMed ID: 26828466
[TBL] [Abstract][Full Text] [Related]
6. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
7. Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.
Ting CT; Kuo CJ; Hu HY; Lee YL; Tsai TH
BMC Complement Altern Med; 2017 Feb; 17(1):118. PubMed ID: 28219357
[TBL] [Abstract][Full Text] [Related]
8. The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs.
Chen SL; Ho CY; Lin WC; Lee CW; Chen YC; Chen JL; Chen HY
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231778
[TBL] [Abstract][Full Text] [Related]
9. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.
Wang ZY; Liu JG; Li H; Yang HM
Am J Chin Med; 2016; 44(8):1525-1541. PubMed ID: 27848250
[TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Shu X; McCulloch M; Xiao H; Broffman M; Gao J
Integr Cancer Ther; 2005 Sep; 4(3):219-29. PubMed ID: 16113029
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
Bishayee A; Politis T; Darvesh AS
Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
[TBL] [Abstract][Full Text] [Related]
13. Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.
Chen SR; Qiu HC; Hu Y; Wang Y; Wang YT
Phytother Res; 2016 Jun; 30(6):863-77. PubMed ID: 26879574
[TBL] [Abstract][Full Text] [Related]
14. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review.
Baby J; Devan AR; Kumar AR; Gorantla JN; Nair B; Aishwarya TS; Nath LR
J Food Biochem; 2021 Jul; 45(7):e13761. PubMed ID: 34028054
[TBL] [Abstract][Full Text] [Related]
15. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial.
Zhai XF; Chen Z; Li B; Shen F; Fan J; Zhou WP; Yang YK; Xu J; Qin X; Li LQ; Ling CQ
J Integr Med; 2013 Mar; 11(2):90-100. PubMed ID: 23506690
[TBL] [Abstract][Full Text] [Related]
16. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms.
Wang X; Wang N; Cheung F; Lao L; Li C; Feng Y
J Integr Med; 2015 May; 13(3):142-64. PubMed ID: 26006028
[TBL] [Abstract][Full Text] [Related]
17. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis.
Mann CD; Neal CP; Garcea G; Manson MM; Dennison AR; Berry DP
Eur J Cancer Prev; 2009 Feb; 18(1):13-25. PubMed ID: 19077560
[TBL] [Abstract][Full Text] [Related]
18. Preventive and therapeutic role of Tanshinone ⅡA in hepatology.
Shi MJ; Dong BS; Yang WN; Su SB; Zhang H
Biomed Pharmacother; 2019 Apr; 112():108676. PubMed ID: 30797157
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Luther DJ; Ohanyan V; Shamhart PE; Hodnichak CM; Sisakian H; Booth TD; Meszaros JG; Bishayee A
Invest New Drugs; 2011 Apr; 29(2):380-91. PubMed ID: 19812893
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the efficacy of photodynamic therapy by a chinese herbal medicine for hepatocellular carcinoma.
Juan M; Minhu C; Yun D; Liang Q
Cancer Biol Ther; 2006 Sep; 5(9):1117-9. PubMed ID: 17035729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
